TD-004

N/A

Report date: 2023/02/27 18:01:43
NME

Base Information

Drug NameTD-004
Drug Alias NameTD-004TD004
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionAnaplastic lymphoma kinase inhibitorsvon Hippel-Lindau disease tumor suppressor degraders
TargetsAnaplastic lymphoma kinasevon Hippel-Lindau disease tumor suppressor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKorea Research Institute Of Chemical TechnologyChungnam National University
China Registration ClassN/A

Develop Information

Active CompaniesKorea Research Institute Of Chemical Technology
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A